These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

995 related items for PubMed ID: 15760632

  • 1. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP, Bayer AJ, Steinhagen-Thiessen E.
    J Neurol Sci; 2005 Mar 15; 229-230():141-6. PubMed ID: 15760632
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 15; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 3. Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials.
    Winblad B, Black SE, Homma A, Schwam EM, Moline M, Xu Y, Perdomo CA, Swartz J, Albert K.
    Curr Med Res Opin; 2009 Nov 15; 25(11):2577-87. PubMed ID: 19735164
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM, Donepezil MSAD Study Investigators Group.
    Int J Geriatr Psychiatry; 2005 Jun 15; 20(6):559-69. PubMed ID: 15920715
    [Abstract] [Full Text] [Related]

  • 5. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V, Haglund A, Kowalski J, Langworth S, Winblad B.
    Dement Geriatr Cogn Disord; 2008 Jun 15; 26(5):458-66. PubMed ID: 18984956
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A, Gauthier S, Perdomo C.
    Int J Geriatr Psychiatry; 2007 Aug 15; 22(8):806-12. PubMed ID: 17199235
    [Abstract] [Full Text] [Related]

  • 7. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.
    Dement Geriatr Cogn Disord; 2009 Aug 15; 27(3):232-9. PubMed ID: 19246907
    [Abstract] [Full Text] [Related]

  • 8. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials.
    Román GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ.
    Dement Geriatr Cogn Disord; 2005 Aug 15; 20(6):338-44. PubMed ID: 16192723
    [Abstract] [Full Text] [Related]

  • 9. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T, Román G, Gauthier S.
    J Neurol Sci; 2004 Nov 15; 226(1-2):63-6. PubMed ID: 15537522
    [Abstract] [Full Text] [Related]

  • 10. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R, Bergman H, Touchon J, Gambina G, He Y, Nagel J, Lane R.
    Curr Med Res Opin; 2006 Mar 15; 22(3):483-94. PubMed ID: 16574032
    [Abstract] [Full Text] [Related]

  • 11. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
    Leroi I, Brandt J, Reich SG, Lyketsos CG, Grill S, Thompson R, Marsh L.
    Int J Geriatr Psychiatry; 2004 Jan 15; 19(1):1-8. PubMed ID: 14716693
    [Abstract] [Full Text] [Related]

  • 12. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia.
    Paci C, Gobbato R, Carboni T, Sanguigni S, Santone A, Curatola L.
    Neurol Sci; 2006 Feb 15; 26(6):435-7. PubMed ID: 16601937
    [Abstract] [Full Text] [Related]

  • 13. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
    Doraiswamy PM, Babyak MA, Hennig T, Trivedi R, White WD, Mathew JP, Newman MF, Blumenthal JA.
    Psychopharmacol Bull; 2007 Feb 15; 40(2):54-62. PubMed ID: 17514186
    [Abstract] [Full Text] [Related]

  • 14. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
    Tinklenberg JR, Kraemer HC, Yaffe K, Ross L, Sheikh J, Ashford JW, Yesavage JA, Taylor JL.
    Am J Geriatr Psychiatry; 2007 Nov 15; 15(11):953-60. PubMed ID: 17974866
    [Abstract] [Full Text] [Related]

  • 15. Donepezil in the treatment of patients with Alzheimer's disease.
    Tsuno N.
    Expert Rev Neurother; 2009 May 15; 9(5):591-8. PubMed ID: 19402770
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R, Donepezil 307 Vascular Dementia Study Group.
    Stroke; 2003 Oct 15; 34(10):2323-30. PubMed ID: 12970516
    [Abstract] [Full Text] [Related]

  • 17. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.
    Neurology; 2009 May 05; 72(18):1555-61. PubMed ID: 19176895
    [Abstract] [Full Text] [Related]

  • 18. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.
    Neurology; 2007 Jul 31; 69(5):459-69. PubMed ID: 17664405
    [Abstract] [Full Text] [Related]

  • 19. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S, Kameda A, Inagaki T, Horiguchi J.
    Psychiatry Clin Neurosci; 2004 Dec 31; 58(6):660-5. PubMed ID: 15601392
    [Abstract] [Full Text] [Related]

  • 20. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R, Touchon J, Bergman H, Gambina G, He Y, Rapatz G, Nagel J, Lane R.
    Curr Med Res Opin; 2005 Aug 31; 21(8):1317-27. PubMed ID: 16083542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.